Study to Compare the Anti-tetanus Neutralizing Antibody Titers and Safety of TNM002 Injection With Human Tetanus Immunoglobulin or Placebo in Adult Volunteers
Clinical trial NCT05625477 · COMPLETED
Trial details
- NCT number
- NCT05625477
- Sponsor
- Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-18
- Primary completion
- 2022-05-29
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.